Novo Nordisk (NYSE:NVO) upgraded to Buy at UBS. Shares up 2% premarket.
AbbVie (NYSE:ABBV) downgraded to Hold at Societe Generale.
Bristol-Myers Squibb (NYSE:BMY) downgraded to Hold at Societe Generale.
Revance Therapeutics (NASDAQ:RVNC) downgraded to Neutral with a $15 (15% upside) price target at Goldman Sachs.
Tandem Diabetes Care (NASDAQ:TNDM) downgraded to Neutral at Guggenheim.
Universal Health Services (NYSE:UHS) downgraded to Neutral with a $104 (38% upside) price target at Bank of America.
https://seekingalpha.com/news/3554092-socgen-cuts-view-on-abbvie-in-premarket-analyst-action
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.